Literature DB >> 23183674

Thyroid gland: thyroid surgery and radioiodine ablation-the surgeon's role.

Markus Luster, Thomas J Musholt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23183674     DOI： 10.1038/nrendo.2012.229

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  8 in total

1.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

2.  Thyroid cancer surgery in Germany: an analysis of the nationwide DRG statistics 2005-2006.

Authors:  Pietro Trocchi; Alexander Kluttig; Henning Dralle; Carsten Sekulla; Martin Biermann; Andreas Stang
Journal:  Langenbecks Arch Surg       Date:  2012-01-10       Impact factor: 3.445

3.  Incidental multifocal papillary microcarcinomas of the thyroid: is subtotal thyroidectomy combined with radioiodine ablation enough?

Authors:  Markus Dietlein; Walter A Luyken; Harald Schicha; Antonio Larena-Avellaneda
Journal:  Nucl Med Commun       Date:  2005-01       Impact factor: 1.690

4.  Guidelines on radioiodine therapy for differentiated thyroid carcinoma: impact on clinical practice.

Authors:  M Biermann; M K Pixberg; U Dörr; M Dietlein; H Schlemmer; J Grimm; T Zajic; U Nestle; S Ladner; S Sepehr-Rezai; S Rosenbaum; C Puskás; P Fostitsch; A Heinecke; A Schuck; N Willich; K W Schmid; H Dralle; O Schober
Journal:  Nuklearmedizin       Date:  2005       Impact factor: 1.379

5.  No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer.

Authors:  Frederik Anton Verburg; Marcel P M Stokkel; Christian Düren; Robbert B T Verkooijen; Uwe Mäder; Johannes W van Isselt; Robert J Marlowe; Johannes W Smit; Christoph Reiners; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-29       Impact factor: 9.236

6.  A comparison of prognostic classification systems for differentiated thyroid carcinoma.

Authors:  Frederik A Verburg; Uwe Mäder; Cas L J J Kruitwagen; Markus Luster; Christoph Reiners
Journal:  Clin Endocrinol (Oxf)       Date:  2009-10-31       Impact factor: 3.478

Review 7.  An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer.

Authors:  Anna M Sawka; James D Brierley; Richard W Tsang; Lehana Thabane; Lorne Rotstein; Amiram Gafni; Sharon Straus; David P Goldstein
Journal:  Endocrinol Metab Clin North Am       Date:  2008-06       Impact factor: 4.741

8.  The relationship between extent of thyroid cancer surgery and use of radioactive iodine.

Authors:  Megan R Haymart; Mousumi Banerjee; Di Yang; Andrew K Stewart; Gerard M Doherty; Ronald J Koenig; Jennifer J Griggs
Journal:  Ann Surg       Date:  2013-08       Impact factor: 12.969
  8 in total
  1 in total

1.  Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas.

Authors:  Aswini Krishnan; Jean Berthelet; Emilie Renaud; Sebastian Rosigkeit; Ute Distler; Eric Stawiski; Jing Wang; Zora Modrusan; Marc Fiedler; Mariann Bienz; Stefan Tenzer; Arno Schad; Wilfried Roth; Bernd Thiede; Somasekar Seshagiri; Thomas J Musholt; Krishnaraj Rajalingam
Journal:  Nat Commun       Date:  2020-04-28       Impact factor: 14.919
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.